HDCN Article Review/Hyperlink

Lederman R, Mendelsohn F, Anderson D, Saucedo J

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial

Lancet (Jun) 359:2053, 2002

The abstract of this paper is available from the Lancet. However, you must register at the Lancet site first as a non-subscriber (you can get there via the journals page of HDCN).

Once you have registered at the Lancet site, click here for the abstract.
         Related Folders:

Return to Home